Enovis Return on Investment 2010-2023 | ENOV
Current and historical return on investment (ROI) values for Enovis (ENOV) over the last 10 years.
| Enovis ROI - Return on Investment Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | LT Investments & Debt | Return on Investment |
| 2023-12-31 | $-0.07B | $3.89B | -1.70% |
| 2023-09-30 | $-0.09B | $3.84B | -2.33% |
| 2023-06-30 | $-0.09B | $3.85B | -3.07% |
| 2023-03-31 | $-0.07B | $3.73B | -3.60% |
| 2022-12-31 | $-0.07B | $3.49B | -2.90% |
| 2022-09-30 | $-0.14B | -4.33% | |
| 2022-06-30 | $-0.14B | -2.88% | |
| 2022-03-31 | $-0.16B | $6.29B | -2.46% |
| 2021-12-31 | $-0.06B | $6.74B | -1.02% |
| 2021-09-30 | $-0.14B | $6.24B | -2.28% |
| 2021-06-30 | $-0.06B | $5.93B | -0.99% |
| 2021-03-31 | $-0.05B | $5.77B | -0.91% |
| 2020-12-31 | $-0.07B | $5.79B | -1.15% |
| 2020-09-30 | $0.20B | $5.65B | 3.42% |
| 2020-06-30 | $0.20B | $5.62B | 3.31% |
| 2020-03-31 | $0.25B | $5.85B | 3.82% |
| 2019-12-31 | $0.20B | $5.77B | 2.91% |
| 2019-09-30 | $0.12B | $7.14B | 1.80% |
| 2019-06-30 | $0.09B | $7.34B | 1.44% |
| 2019-03-31 | $0.09B | $7.78B | 1.68% |
| 2018-12-31 | $0.15B | $4.67B | 3.20% |
| 2018-09-30 | $0.07B | $4.61B | 1.52% |
| 2018-06-30 | $0.11B | $4.61B | 2.33% |
| 2018-03-31 | $0.14B | $4.96B | 2.84% |
| 2017-12-31 | $0.14B | $4.78B | 2.88% |
| 2017-09-30 | $0.26B | $4.85B | 5.70% |
| 2017-06-30 | $0.25B | $4.70B | 5.44% |
| 2017-03-31 | $0.25B | $4.46B | 5.55% |
| 2016-12-31 | $0.24B | $4.38B | 5.22% |
| 2016-09-30 | $0.23B | $4.55B | 4.90% |
| 2016-06-30 | $0.21B | $4.56B | 4.55% |
| 2016-03-31 | $0.24B | $4.68B | 4.99% |
| 2015-12-31 | $0.27B | $4.67B | 5.60% |
| 2015-09-30 | $0.33B | $4.84B | 6.81% |
| 2015-06-30 | $0.40B | $4.81B | 8.20% |
| 2015-03-31 | $0.40B | $4.68B | 7.92% |
| 2014-12-31 | $0.41B | $4.88B | 8.20% |
| 2014-09-30 | $0.42B | $5.15B | 8.76% |
| 2014-06-30 | $0.41B | $5.46B | 8.98% |
| 2014-03-31 | $0.42B | $4.50B | 10.27% |
| 2013-12-31 | $0.41B | $4.20B | 10.51% |
| 2013-09-30 | $0.34B | $3.96B | 8.96% |
| 2013-06-30 | $0.29B | $3.82B | 7.67% |
| 2013-03-31 | $0.24B | $3.51B | 6.31% |
| 2012-12-31 | $0.14B | $3.85B | 3.64% |
| 2012-09-30 | $0.08B | $3.84B | 2.71% |
| 2012-06-30 | $0.03B | $3.76B | 1.59% |
| 2012-03-31 | $-0.01B | $3.92B | -0.83% |
| 2011-12-31 | $0.03B | $0.29B | 8.08% |
| 2011-09-30 | $0.05B | $0.31B | 17.15% |
| 2011-06-30 | $0.06B | $0.33B | 18.58% |
| 2011-03-31 | $0.05B | $0.31B | 15.46% |
| 2010-12-31 | $0.04B | $0.29B | 12.44% |
| 2010-09-30 | $0.03B | $0.30B | 8.81% |
| 2010-06-30 | $0.03B | $0.26B | 9.32% |
| 2010-03-31 | $0.03B | $0.27B | 10.31% |
| 2009-12-31 | $0.04B | $0.30B | 14.40% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $3.030B | $1.707B |
| Enovis Corporation is a medical technology company. Its range of products, services and integrated technologies fuel active lifestyles in orthopedics and beyond. Enovis Corporation, formerly known as Colfax Corporation, is based in Wilmington, DE. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GE HealthCare Technologies (GEHC) | United States | $39.354B | 21.89 |
| Inspire Medical Systems (INSP) | United States | $7.194B | 0.00 |
| IRhythm Technologies (IRTC) | United States | $3.483B | 0.00 |
| Axonics (AXNX) | United States | $3.401B | 0.00 |
| 10x Genomics (TXG) | United States | $3.288B | 0.00 |
| Azenta (AZTA) | United States | $2.910B | 237.18 |
| Olink Holding AB (publ) (OLK) | Sweden | $2.840B | 0.00 |
| Hims & Hers Health (HIMS) | United States | $2.678B | 0.00 |
| Privia Health (PRVA) | United States | $2.167B | 96.11 |
| Schrodinger (SDGR) | United States | $1.733B | 0.00 |
| Omnicell (OMCL) | United States | $1.279B | 31.30 |
| Phreesia (PHR) | United States | $1.162B | 0.00 |
| Definitive Healthcare (DH) | United States | $0.823B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.762B | 0.00 |
| Standard BioTools (LAB) | United States | $0.708B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.601B | 0.00 |
| Talkspace (TALK) | United States | $0.527B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.353B | 0.00 |
| Clover Health Investments (CLOV) | United States | $0.337B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.328B | 0.00 |
| Pulmonx (LUNG) | United States | $0.281B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.162B | 0.00 |
| American Well (AMWL) | United States | $0.153B | 0.00 |
| MSP Recovery (LIFW) | United States | $0.141B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.141B | 0.00 |
| Augmedix (AUGX) | United States | $0.139B | 0.00 |
| Outset Medical (OM) | United States | $0.124B | 0.00 |
| TruBridge (TBRG) | United States | $0.118B | 5.03 |
| 111 (YI) | China | $0.086B | 0.00 |
| SHL Telemedicine (SHLT) | Israel | $0.082B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.073B | 0.00 |
| HeartBeam (BEAT) | United States | $0.053B | 0.00 |
| Zepp Health (ZEPP) | China | $0.052B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.048B | 0.00 |
| Movano (MOVE) | United States | $0.047B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.035B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.023B | 0.00 |
| Cue Health (HLTH) | United States | $0.022B | 0.00 |
| Akili (AKLI) | United States | $0.019B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.019B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.018B | 0.00 |
| CareCloud (CCLD) | United States | $0.017B | 0.00 |
| ETAO (ETAO) | United States | $0.015B | 0.00 |
| Centogene (CNTG) | Germany | $0.013B | 0.00 |
| Biotricity (BTCY) | United States | $0.012B | 0.00 |
| Transgenomic (PRPO) | United States | $0.009B | 0.00 |
| HeartSciences (HSCS) | United States | $0.006B | 0.00 |
| Syra Health (SYRA) | United States | $0.006B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.006B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.006B | 0.00 |
| Zhongchao (ZCMD) | China | $0.003B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.000B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.000B | 0.00 |